A deregulated PI3K pathway is frequently encountered in gastric cancer (18,19) and it appears to play an important role in the aggressive nature of this disease while perhaps contributing to the lack of susceptibility to cytotoxic chemotherapy. This evidence concerns the gene PIK3CA and gastric cancer.